| 1996 |
NET1 was isolated as a novel oncogene encoding a ~54 kDa protein containing the Dbl-Homology (DH) motif; truncation of its N-terminus activated transforming activity, causing NIH3T3 focus formation and tumorigenicity in nude mice, indicating the N-terminus acts as a negative regulatory domain. |
Expression cDNA cloning, focus formation assay, nude mouse tumorigenicity assay, fluorescence in situ hybridization (chromosomal mapping to 10p15) |
Oncogene |
High |
8649828
|
| 2002 |
NET1 localizes to the nucleus via two N-terminal nuclear localization signals (NLS); the oncogenic truncated form lacking the N-terminus is cytoplasmic. Forced cytoplasmic localization of wild-type NET1 is sufficient to activate RhoA, demonstrating that nuclear sequestration is the primary mechanism keeping NET1 inactive. The PH domain additionally functions as a nuclear export signal, independently of catalytic activity. |
Subcellular fractionation, immunofluorescence, NLS mutation analysis, forced cytoplasmic localization constructs, RhoA activation assays |
The Journal of biological chemistry |
High |
11839749
|
| 2001 |
NET1 is a guanine nucleotide exchange factor specific for RhoA whose activity is required for TGF-β-induced actin stress fiber formation. TGF-β induces NET1 expression via the Smad signaling pathway, and a dominant-negative NET1 (L392E) or RhoA kinase inhibitor Y-27632 blocks TGF-β-dependent stress fiber formation. |
Microarray gene expression analysis, overexpression of wild-type and dominant-negative NET1, RhoA kinase inhibitor treatment, dominant-negative Smad3 stable cell line, stress fiber assay |
The Journal of biological chemistry |
High |
11278519
|
| 2005 |
PAK1 phosphorylates NET1 on serines 152, 153, and 538 in vitro and on S152 in cells. Phosphomimetic substitution at S152/S153 (glutamate) down-regulates NET1 GEF activity in vitro and inhibits stress fiber formation in cells. Rac1 stimulates S152 phosphorylation in a PAK1-dependent manner, establishing a Rac1→PAK1→NET1 inhibitory pathway to suppress RhoA. |
In vitro kinase assay, phospho-specific antibody, Ser→Glu phosphomimetic mutants, actin stress fiber assay, constitutively active PAK1 co-expression |
The Journal of biological chemistry |
High |
15684429
|
| 2007 |
NET1 interacts through its C-terminal PDZ-binding motif with tumor suppressor proteins of the Dlg family (Dlg1/SAP97, SAP102, PSD95). This interaction promotes translocation of Dlg proteins to nuclear PML-body-associated subdomains. Oncogenic NET1 (cytoplasmic) sequesters Dlg proteins in the cytosol, reducing their tumor-suppressor activity; co-expression of Dlg1 or SAP102 reduces oncogenic NET1 transforming potential. |
Co-immunoprecipitation, immunofluorescence, transformation assay, deletion mutant analysis (PDZ-binding motif) |
Molecular and cellular biology |
High |
17938206
|
| 2008 |
DNA damage (cytolethal distending toxin or ionizing radiation) causes dephosphorylation of NET1 at a critical inhibitory site, activating NET1's GEF activity toward nuclear RhoA. NET1-dependent RhoA activation promotes actin stress fiber formation and cell survival via p38 MAPK and its downstream target MK2. |
Dominant-negative NET1 expression, siRNA knockdown, phosphorylation state analysis, RhoA activation assay, p38/MK2 pathway readout |
PloS one |
High |
18509476
|
| 2009 |
NET1 interacts directly with the first two PDZ domains of Dlg1 via its C-terminal PDZ-binding motif. Dlg1 interaction protects NET1 from proteasome-mediated degradation, stabilizing it and increasing NET1-stimulated RhoA activation. Cell-cell contact enhances NET1 stability through increased NET1–Dlg1 interaction; disruption of E-cadherin contacts (by calcium removal or TGF-β) reduces NET1–Dlg1 interaction and promotes NET1 ubiquitylation. |
Co-immunoprecipitation, pulldown with PDZ domain constructs, ubiquitylation assay, proteasome inhibitor treatment, RhoA activation assay, calcium chelation and TGF-β treatment |
The Journal of biological chemistry |
High |
19586902
|
| 2011 |
Nuclear NET1 exists in an active (GTP-exchange-competent) form. A fraction of RhoA resides in the nucleus in GTP-bound form, and NET1 activates nuclear RhoA. Ionizing radiation specifically activates the nuclear pool of RhoA via NET1 (nuclear-only), while cytoplasmic RhoA activity remains unchanged; this nuclear NET1/RhoA activation occurs even in isolated nuclei. |
Affinity precipitation of active GEFs from subcellular fractions, pull-down of GTP-RhoA, siRNA knockdown of NET1, ionizing radiation treatment of whole cells and isolated nuclei |
PloS one |
High |
21390328
|
| 2011 |
The nuclear GEFs NET1 and Ect2 activate RhoB after ionizing radiation or chemotherapy, promoting apoptotic signaling (JNK phosphorylation, Bim induction). Simultaneous siRNA knockdown of NET1 and Ect2 inhibited IR-induced RhoB activation, reduced apoptotic signaling, and protected cells from IR-induced cell death. |
siRNA knockdown of NET1 and Ect2, RhoB activation assay, JNK phosphorylation and Bim expression readout, cell death assay |
PloS one |
Medium |
21373644
|
| 2011 |
TGF-β selectively induces the Net1A isoform (Net1 isoform 2) via Smad and MEK/ERK signaling, leading to cytoplasmic Net1A accumulation and RhoA activation. Long-term TGF-β treatment causes Net1 mRNA downregulation and Net1A protein degradation by the proteasome, triggering EMT. miR-24 post-transcriptionally suppresses Net1A expression and is involved in TGF-β-induced EMT and breast cancer cell invasion. |
isoform-specific RT-PCR, siRNA knockdown, proteasome inhibitor treatment, Smad/MEK pathway inhibitors, miR-24 luciferase reporter assay, migration/invasion assay |
Oncogene |
High |
21986943
|
| 2012 |
NET1 interacts with CARMA1 and CARMA3 proteins and induces NF-κB activation. NET1 cooperates with BCL10 and CARMA proteins to stimulate NF-κB activity, and shRNA-mediated NET1 knockdown impairs NF-κB activation by stimuli requiring the CARMA-BCL10-MALT1 complex. |
Co-immunoprecipitation coupled with mass spectrometry, NF-κB reporter assay, shRNA knockdown |
The Journal of biological chemistry |
Medium |
22343628
|
| 2012 |
Rac1 activation relocates Net1A from the nucleus to the plasma membrane, stimulates Net1A catalytic activity, and protects Net1A from proteasome-mediated degradation. Net1A (but not Net1) is required for cell spreading on collagen, myosin light chain phosphorylation, and focal adhesion maturation. Net1A relocalization by Rac1 does not require Net1A's catalytic activity, PH domain, or C-terminus, demonstrating a non-catalytic mechanism of regulation. |
Rac1 constitutively active expression, proteasome inhibitor treatment, immunofluorescence, GEF activity assay, MLC phosphorylation assay, isoform-specific siRNA knockdown, cell spreading assay |
Molecular and cellular biology |
High |
23184663
|
| 2013 |
Net1A isoform localizes to focal adhesions, interacts with focal adhesion kinase (FAK), and is required for FAK activation, focal adhesion maturation, myosin light chain phosphorylation, and trailing edge retraction during migration. Net1A loss shifts cells from amoeboid to mesenchymal invasion, with elevated β1-integrin and MT1-MMP expression. |
Co-immunoprecipitation of Net1A with FAK, immunofluorescence to focal adhesions, MLC phosphorylation assay, isoform-specific knockdown, Matrigel invasion assay |
Molecular and cellular biology |
High |
23689132
|
| 2013 |
NET1 overexpression or knockdown causes mitotic defects including chromosome mis-congression and unstable kinetochore-microtubule attachments, activating the spindle assembly checkpoint. These mitotic functions are independent of RhoA or RhoB activation, as catalytically inactive Net1 rescues mitotic phenotypes. NET1 is required for centrosomal activation of PAK and Aurora A kinase. |
Net1 overexpression and siRNA knockdown, immunofluorescence for chromosome alignment and kinetochore-microtubule attachments, spindle assembly checkpoint assay, catalytically inactive mutant rescue, centrosome Aurora A and PAK activation assay |
Molecular biology of the cell |
High |
23864709
|
| 2015 |
Net1A contains two NLS sequences in its N-terminus; residues surrounding the second NLS are acetylated. Deacetylase inhibition or active Rac1 promotes Net1A acetylation and cytoplasmic relocalization. Arginine substitution at the N-terminal acetylation sites prevents cytoplasmic accumulation; glutamine substitution (mimicking acetylation) is sufficient for Net1A relocalization, RhoA activation, F-actin accumulation, and focal adhesion maturation. |
Acetylation site mapping, deacetylase inhibitor treatment, arginine/glutamine substitution mutants, immunofluorescence, RhoA activation assay, focal adhesion assay, rescue in Net1 KO MEFs |
Journal of cell science |
High |
25588829
|
| 2016 |
Zebrafish net1 GEF activity is required for Wnt/β-catenin signaling activation during embryonic dorsal axis formation. Net1 dissociates and activates PAK1 dimers; PAK1 then phosphorylates β-catenin on S675, promoting transcription of Wnt target genes. |
Loss- and gain-of-function in zebrafish embryos, GEF-dead mutant analysis, β-catenin S675 phosphorylation assay, PAK1 dimer dissociation assay |
Cell research |
Medium |
27910850
|
| 2017 |
Nuclear NET1 interacts with Smad2 in a GEF-activity-independent manner and promotes Smad2 activation by enhancing recruitment of the co-activator p300 to the transcriptional complex, facilitating Nodal signal transduction and mesendoderm formation in zebrafish. |
Co-immunoprecipitation of Net1 with Smad2 and p300, GEF-dead mutant analysis, zebrafish loss- and gain-of-function experiments, reporter assays for Nodal signaling |
Journal of cell science |
Medium |
28778986
|
| 2018 |
JNK pathway activation is required and sufficient for Net1A cytosolic relocalization. JNK1 directly phosphorylates Net1A on S52; alanine substitution at S52 prevents relocalization by EGF or JNK activation, while glutamic acid substitution (phosphomimetic) causes spontaneous cytosolic accumulation, elevated RhoA signaling, MLC2 phosphorylation, F-actin accumulation, cell motility, and Matrigel invasion. CRM1 mediates nuclear export of Net1A downstream of JNK. |
MAPK pathway inhibitors, constitutively active JNK expression, S52A/S52E mutagenesis, CRM1 inhibition (leptomycin B), in vitro kinase assay, immunofluorescence, RhoA activation assay, MLC phosphorylation, invasion assay |
Journal of cell science |
High |
29361525
|
| 2018 |
Crystal structure of RhoA/Net1 DH-domain heterodimer solved at 2 Å resolution. Structural and molecular dynamics analysis defined the RhoA–Net1 interaction interface. Short RhoA-derived peptides (e.g., EVKHF, residues 102-106) targeting this interface can disrupt the RhoA/Net1 interaction and reduce GEF-catalyzed nucleotide exchange (IC50 ~100 µM). |
X-ray crystallography (2 Å), molecular dynamics simulation, peptide-based pulldown/binding assay, GDP exchange assay |
The Journal of biological chemistry |
High |
29695506
|
| 2021 |
Cdk1 phosphorylates NET1 on multiple sites in its N-terminal regulatory domain and C-terminus during mitosis. Substitution of the major Cdk1 phosphorylation sites with acidic residues inhibits NET1's interaction with RhoA; Cdk1 inhibition increases NET1 activity, promotes its plasma membrane localization, and stimulates cortical F-actin accumulation. Acidic substitution of Cdk1 sites reduces Net1-overexpression-induced spindle polarity defects. |
In vitro Cdk1 kinase assay, phospho-specific antibody generation, Ala/Asp substitution mutants, RhoA interaction assay, immunofluorescence for plasma membrane localization and F-actin, spindle polarity analysis, Cdk1 inhibitor treatment |
Cellular signalling |
High |
33465404
|
| 2023 |
EGF activates a Src→Abl1 kinase cascade that phosphorylates Net1A on Y373, promoting Net1A cytosolic localization. Y373F substitution prevents cytosolic accumulation; Y373D (phosphomimetic) is sufficient for cytosolic Net1A localization, RhoA activation, MLC2 phosphorylation, F-actin accumulation, cell motility, and Matrigel invasion. Abl1-driven cytosolic localization requires Y373 but acts independently of the JNK-targeted S52 site. |
EGF stimulation, Src and Abl1 inhibitors, in vitro kinase assay, Y373F/Y373D mutagenesis, immunofluorescence, RhoA activation assay, MLC phosphorylation, invasion assay, Net1A knockdown rescue |
The Journal of biological chemistry |
High |
37271338
|
| 2024 |
NET1 is required for spindle assembly and actin dynamics during mouse oocyte meiosis. After GVBD, NET1 relocalizes from nucleus to cytoplasm and accumulates on the meiotic spindle at MI/MII. Net1 depletion causes first polar body extrusion failure and asymmetric division defects. NET1 protects RAC1 from HACE1-mediated degradation; exogenous RAC1 expression rescues Net1 depletion phenotypes, establishing a NET1–HACE1–RAC1 pathway governing meiotic cytoskeletal organization. |
siRNA knockdown in mouse oocytes, immunostaining/confocal microscopy for spindle and actin, western blot for RAC1 levels, exogenous RAC1 rescue experiment, mass spectrometry |
Reproductive biology and endocrinology |
Medium |
38169395
|
| 2025 |
NET1 cytosolic localization is required for Src kinase activation in breast cancer cells. Endogenous NET1 and Src interact; NET1 expression is required for full Src activation at Y419. This effect requires NET1 cytoplasmic localization and its interaction with scaffolding protein Dlg1, but NOT Net1 catalytic activity toward RhoA. Dlg1 knockdown prevents Src activation by NET1 and blocks Net1–Src interaction. |
Co-immunoprecipitation of endogenous NET1 and Src, Dlg1 siRNA knockdown, cytosol-targeted and catalytically inactive NET1 mutants, Src Y419 phosphorylation readout, cell motility assay, Matrigel invasion assay |
Molecular and cellular biology |
Medium |
40765140
|
| 2025 |
NET1/ARHGEF8 is expressed in vascular smooth muscle cells (VSMCs) and is mechanosensitive. Under physiological cyclic stretch, NET1 localizes to the cytosol and interacts with RhoA. Loss of NET1 blunts stretch-induced MYPT1 phosphorylation and impairs cell adhesion and spreading. Expression of a cytosolic NET1 mutant promotes contractile gene expression and increases cell contractile capacity. |
Cyclic stretch experiments, immunofluorescence for subcellular localization, MYPT1 phosphorylation assay, cell adhesion/spreading assay, cytosolic NET1 mutant expression, gene expression analysis |
bioRxivpreprint |
Medium |
|
| 2024 |
Net1 mRNA is specifically localized to dermal-epidermal junction (DEJ) protrusion-like structures in stratified squamous epithelia. This mRNA localization dictates Net1 protein distribution and its RhoA GEF activity at that site. Disrupting Net1 mRNA localization alters DEJ morphology and keratinocyte-matrix connections; altered RhoA activity is sufficient to alter DEJ ultrastructure. |
In situ hybridization/FISH for mRNA localization in mouse epithelium, mRNA localization disruption experiments, RhoA activity assay, electron microscopy of DEJ ultrastructure |
bioRxivpreprint |
Medium |
|
| 2010 |
In retinal pigment epithelial cells, Smad3 directly transcriptionally induces NET1 expression in response to TGF-β1. NET1 is necessary for TGF-β1-induced RhoA activation and cytoskeletal reorganization (N-cadherin expression, stress fibers); NET1 interacts with RhoA in the cytoplasm. Dominant-negative Smad3 or constitutively active Smad7 blocked NET1 induction and prevented NET1–RhoA interaction. |
siRNA knockdown of NET1, dominant-negative Smad3 and constitutively active Smad7 cell lines, Co-immunoprecipitation of NET1 with RhoA, RhoA activation assay, immunofluorescence |
The Journal of biological chemistry |
High |
20547485
|